{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:48:27Z","timestamp":1793245707014,"version":"4.5.0"},"reference-count":43,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polygenic risk scores (PRS) are increasingly transitioning from research tools into instruments with direct clinical relevance. This review addresses both opportunities and challenges of PRS across disease contexts. Key applications include risk stratification in multifactorial and monogenic diseases, diagnostic support in etiologically heterogeneous disorders, and pharmacogenomic stratification. These are accompanied by substantial challenges, including limited transferability across diverse populations, insufficient methodological standardization, and barriers to effective risk communication. PRS hold considerable potential to contribute to a more individualized, predictive, and preventive medicine, provided that scientific rigor and responsibility guide their clinical translation.<\/jats:p>","DOI":"10.1515\/medgen-2026-3016","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:57:23Z","timestamp":1783439843000},"page":"169-176","source":"Crossref","is-referenced-by-count":2,"title":["Polygenic risk scores in clinical applications\u00a0\u2013 opportunities and challenges"],"prefix":"10.1515","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-6457","authenticated-orcid":false,"given":"Johannes","family":"Schumacher","sequence":"first","affiliation":[{"name":"Philipps University Marburg & University Hospital of Marburg Institute of Human Genetics Baldingerstr. Marburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-2464","authenticated-orcid":false,"given":"Markus M.","family":"N\u00f6then","sequence":"additional","affiliation":[{"name":"University of Bonn & University Hospital of Bonn Institute of Human Genetics Venusberg-Campus 1 Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-465X","authenticated-orcid":false,"given":"Stefanie","family":"Heilmann-Heimbach","sequence":"additional","affiliation":[{"name":"University Hospital of Bonn Institute of Human Genetics Sigmund-Freud-Str. 25 Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026072106573427155_j_medgen-2026-3016_ref_001","doi-asserted-by":"crossref","unstructured":"Gallagher, C.S., G.S. Ginsburg, and A. Musick, Biobanking with genetics shapes precision medicine and global health. Nat Rev Genet, 2025. 26(3): p. 191\u2013202.","DOI":"10.1038\/s41576-024-00794-y"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_002","doi-asserted-by":"crossref","unstructured":"Marston, N.A., et al., Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention. JAMA Cardiol, 2023. 8(2): p. 130\u2013137.","DOI":"10.1001\/jamacardio.2022.4466"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_003","unstructured":"Goff, D.C., Jr., et al., 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014. 63(25 Pt B): p. 2935\u20132959."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_004","doi-asserted-by":"crossref","unstructured":"Fergus, K.B., et al., Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial. Genome Med, 2025. 17(1): p. 97.","DOI":"10.1186\/s13073-025-01524-7"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_005","doi-asserted-by":"crossref","unstructured":"Lee, A., et al., BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med, 2019. 21(8): p. 1708\u20131718.","DOI":"10.1038\/s41436-018-0406-9"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_006","doi-asserted-by":"crossref","unstructured":"Sessa, C., et al., Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol, 2023. 34(1): p. 33\u201347.","DOI":"10.1016\/j.annonc.2022.10.004"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_007","doi-asserted-by":"crossref","unstructured":"Yang, X., et al., Validation of the BOADICEA model in a prospective cohort of BRCA1\/2 pathogenic variant carriers. J Med Genet, 2024. 61(8): p. 803\u2013809.","DOI":"10.1136\/jmg-2024-109943"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_008","doi-asserted-by":"crossref","unstructured":"Gallagher, S., et al., Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes. JAMA Netw Open, 2020. 3(7): p. e208501.","DOI":"10.1001\/jamanetworkopen.2020.8501"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_009","doi-asserted-by":"crossref","unstructured":"Fahed, A.C., et al., Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun, 2020. 11(1): p. 3635.","DOI":"10.1038\/s41467-020-17374-3"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_010","doi-asserted-by":"crossref","unstructured":"Rodriguez, V., et al., Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study. Psychol Med, 2023. 53(8): p. 3396\u20133405.","DOI":"10.1017\/S0033291721005456"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_011","unstructured":"EMA, European Public Assessment Report: EMA\/63941\/2025 (Leqembi (lecanemab)): https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi. 2015."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_012","doi-asserted-by":"crossref","unstructured":"Damask, A., et al., Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Circulation, 2020. 141(8): p. 624\u2013636.","DOI":"10.1161\/CIRCULATIONAHA.119.044434"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_013","doi-asserted-by":"crossref","unstructured":"Marston, N.A., et al., Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Circulation, 2020. 141(8): p. 616\u2013623.","DOI":"10.1161\/CIRCULATIONAHA.119.043805"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_014","doi-asserted-by":"crossref","unstructured":"Mega, J.L., et al., Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet, 2015. 385(9984): p. 2264\u20132271.","DOI":"10.1016\/S0140-6736(14)61730-X"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_015","doi-asserted-by":"crossref","unstructured":"Fahed, A.C., A.A. Philippakis, and A.V. Khera, The potential of polygenic scores to improve cost and efficiency of clinical trials. Nat Commun, 2022. 13(1): p. 2922.","DOI":"10.1038\/s41467-022-30675-z"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_016","doi-asserted-by":"crossref","unstructured":"Singh, S., et al., Pharmacogenomics polygenic risk score: Ready or not for prime time? Clin Transl Sci, 2024. 17(8): p. e13893.","DOI":"10.1111\/cts.13893"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_017","doi-asserted-by":"crossref","unstructured":"Wand, H., et al., Improving reporting standards for polygenic scores in risk prediction studies. Nature, 2021. 591(7849): p. 211\u2013219.","DOI":"10.1038\/s41586-021-03243-6"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_018","doi-asserted-by":"crossref","unstructured":"Lambert, S.A., et al., Enhancing the Polygenic Score Catalog with tools for score calculation and ancestry normalization. Nat Genet, 2024. 56(10): p. 1989\u20131994.","DOI":"10.1038\/s41588-024-01937-x"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_019","doi-asserted-by":"crossref","unstructured":"Kachuri, L., et al., Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet, 2024. 25(1): p. 8\u201325.","DOI":"10.1038\/s41576-023-00637-2"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_020","doi-asserted-by":"crossref","unstructured":"Kichaev, G., et al., Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am J Hum Genet, 2019. 104(1): p. 65\u201375.","DOI":"10.1016\/j.ajhg.2018.11.008"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_021","doi-asserted-by":"crossref","unstructured":"Duncan, L., et al., Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun, 2019. 10(1): p. 3328.","DOI":"10.1038\/s41467-019-11112-0"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_022","doi-asserted-by":"crossref","unstructured":"Wang, Y., et al., Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores. Annu Rev Biomed Data Sci, 2022. 5: p. 293\u2013320.","DOI":"10.1146\/annurev-biodatasci-111721-074830"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_023","doi-asserted-by":"crossref","unstructured":"Cerezo, M., et al., The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res, 2025. 53(D1): p. D998-D1005.","DOI":"10.1093\/nar\/gkae1070"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_024","doi-asserted-by":"crossref","unstructured":"Mostafavi, H., et al., Variable prediction accuracy of polygenic scores within an ancestry group. Elife, 2020. 9.","DOI":"10.7554\/eLife.48376"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_025","doi-asserted-by":"crossref","unstructured":"Fatumo, S., et al., Polygenic risk scores for disease risk prediction in Africa: current challenges and future directions. Genome Med, 2023. 15(1): p. 87.","DOI":"10.1186\/s13073-023-01245-9"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_026","doi-asserted-by":"crossref","unstructured":"Kullo, I.J., et al., The PRIMED Consortium: Reducing disparities in polygenic risk assessment. Am J Hum Genet, 2024. 111(12): p. 2594\u20132606.","DOI":"10.1016\/j.ajhg.2024.10.010"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_027","doi-asserted-by":"crossref","unstructured":"Ruan, Y., et al., Improving polygenic prediction in ancestrally diverse populations. Nat Genet, 2022. 54(5): p. 573\u2013580.","DOI":"10.1038\/s41588-022-01054-7"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_028","unstructured":"Verma, A., et al., Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science, 2024. 385(6706): p. eadj1182."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_029","doi-asserted-by":"crossref","unstructured":"All of Us Research Program, I., et al., The \u201cAll of Us\u201d Research Program. N Engl J Med, 2019. 381(7): p. 668\u2013676.","DOI":"10.1056\/NEJMsr1809937"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_030","doi-asserted-by":"crossref","unstructured":"Chen, Z., et al., China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol, 2011. 40(6): p. 1652\u201366.","DOI":"10.1093\/ije\/dyr120"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_031","unstructured":"Nagai, A., et al., Overview of the BioBank Japan Project: Study design and profile. J Epidemiol, 2017. 27(3S): p. S2-S8."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_032","doi-asserted-by":"crossref","unstructured":"Xiang, R., et al., Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. Genome Med, 2024. 16(1): p. 33.","DOI":"10.1186\/s13073-024-01304-9"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_033","doi-asserted-by":"crossref","unstructured":"Braillon, A., Letter by Braillon Regarding Article, \u201cPolygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting\u201d. Circulation, 2017. 136(22): p. 2204\u20132205.","DOI":"10.1161\/CIRCULATIONAHA.117.028763"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_034","doi-asserted-by":"crossref","unstructured":"Sanderson, S.C. and M. Inouye, Psychological and behavioural considerations for integrating polygenic risk scores for disease into clinical practice. Nat Hum Behav, 2025. 9(6): p. 1098\u20131106.","DOI":"10.1038\/s41562-025-02200-x"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_035","doi-asserted-by":"crossref","unstructured":"Hanley, M., et al., The development and evaluation of polygenic risk score reports: A systematized review of the literature. Genet Med, 2025. 27(7): p. 101426.","DOI":"10.1016\/j.gim.2025.101426"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_036","doi-asserted-by":"crossref","unstructured":"Polygenic Risk Score Task Force of the International Common Disease, A., Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med, 2021. 27(11): p. 1876\u20131884.","DOI":"10.1038\/s41591-021-01549-6"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_037","doi-asserted-by":"crossref","unstructured":"Abu-El-Haija, A., et al., The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 2023. 25(5): p. 100803.","DOI":"10.1016\/j.gim.2023.100803"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_038","unstructured":"Linder, J.E., et al., Returning integrated genomic risk and clinical recommendations: The eMERGE study. Genet Med, 2023. 25(4): p. 100006."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_039","unstructured":"GEKO, F\u00fcnfter T\u00e4tigkeitsbericht der Gendiagnostik-Kommission: https:\/\/www.rki.de\/DE\/Institut\/Organisation\/Leitungsstab\/GEKO\/Taetigkeitsberichte\/Taetigkeitsbericht_05.pdf?__blob=publicationFile&v=3. 2025: p. 43\u201344."},{"key":"2026072106573427155_j_medgen-2026-3016_ref_040","doi-asserted-by":"crossref","unstructured":"Turley, P., et al., Problems with Using Polygenic Scores to Select Embryos. N Engl J Med, 2021. 385(1): p. 78\u201386.","DOI":"10.1056\/NEJMsr2105065"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_041","doi-asserted-by":"crossref","unstructured":"Capalbo, A., et al., Screening embryos for polygenic disease risk: a review of epidemiological, clinical, and ethical considerations. Hum Reprod Update, 2024. 30(5): p. 529\u2013557.","DOI":"10.1093\/humupd\/dmae012"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_042","doi-asserted-by":"crossref","unstructured":"Forzano, F., et al., The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice. Eur J Hum Genet, 2022. 30(5): p. 493\u2013495.","DOI":"10.1038\/s41431-021-01000-x"},{"key":"2026072106573427155_j_medgen-2026-3016_ref_043","doi-asserted-by":"crossref","unstructured":"Namba, S., et al., Inconsistent embryo selection across polygenic score methods. Nat Hum Behav, 2024. 8(12): p. 2264\u20132267.","DOI":"10.1038\/s41562-024-02019-y"}],"container-title":["Medizinische Genetik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2026-3016\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2026-3016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:59:06Z","timestamp":1784617146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/medgen-2026-3016\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,8]]},"published-print":{"date-parts":[[2026,7,7]]}},"alternative-id":["10.1515\/medgen-2026-3016"],"URL":"https:\/\/doi.org\/10.1515\/medgen-2026-3016","relation":{},"ISSN":["1863-5490","0936-5931"],"issn-type":[{"value":"1863-5490","type":"electronic"},{"value":"0936-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}